Global leaders in autoimmune research gathered for the 2025 Colton Consortium Symposium last month, sharing breakthroughs from foundational science to translational therapies and forging collaborations to improve patient lives worldwide.
A promising new study published online in Cell by NYU Langone Health researchers uncovers a targeted strategy for treating autoimmune diseases such as type 1 diabetes, hepatitis, and multiple sclerosis.
The Colton Center for Autoimmunity at Yale University presented a showcase on Colton-funded research featuring investigators from across the Consortium.
The 2025 Penn Colton Center Symposium convened 150+ experts to explore breakthroughs in immune health and spotlight Penn’s leadership, future headquarters, and innovations in autoimmunity research and precision medicine.
Yale researchers, including members of the Colton Center for Autoimmunity at Yale, have uncovered a novel lupus-associated autoantibody that can enhance immune responses against aggressive cancers like glioblastoma.
To accelerate the development of next-generation diagnostics and therapies for autoimmune disease, the Colton Center for Autoimmunity at Penn—working in partnership with the broader Colton Consortium—has launched two new Centers of Excellence.
The Colton Center for Autoimmunity at Yale is pleased to announce the eleven 2024 Yale projects selected for their promising research in autoimmunity and allergic diseases.
The Colton Center for Autoimmune Immunity at Tel Aviv University put forth several calls for proposals to fund autoimmune disease research—learn more about the winning research teams.
The Colton Center for Autoimmunity at the University of Pennsylvania has issued an RFA to establish new Centers of Excellence (COEs) to transform the landscape of autoimmune research.
Connecticut's biggest entrepreneurship event, convening innovators, investors, and industry for panels, speakers, and networking in the arts, biotech, climate, health, and tech.
Dive into the inspiring stories and accomplishments of the recipients of The Philadelphia Citizen's first-ever Citizen of the Year Awards. Featuring David Fajgenbaum from the Colton Center for Autoimmunity at Penn.
The Colton Center for Autoimmunity at Yale has awarded seven faculty-led projects a total of $750K to fund research on autoimmune and allergic diseases, including celiac disease, diabetes, and inflammatory skin diseases.
The study from NYU Grossman School of Medicine found that growths of the gut bacterium Ruminococcus blautia gnavus in lupus patients coincide with disease flare-ups, suggesting a strong link between these bacterial blooms and severe forms of lupus.
On April 18, 2023, the Colton Center for Autoimmunity at Penn hosted its first annual Symposium, bringing together experts across disciplines to discuss advances in autoimmune research.
New center enabled by a generous gift of $10 million from Judith and Stewart Colton
Center for autoimmune research brings together star faculty, powering next generation of autoimmune disease advances
The University of Pennsylvania's Perelman School of Medicine has launched the Colton Center for Autoimmunity, supported by a $10 million dollar donation from Stewart and Judy Colton, to enhance autoimmune research and patient care.
Yale University has launched the Colton Center for Autoimmunity, supported by a donation from Stewart and Judy Colton, to enhance autoimmune research and patient care.
Global leaders in autoimmune research gathered for the 2025 Colton Consortium Symposium last month, sharing breakthroughs from foundational science to translational therapies and forging collaborations to improve patient lives worldwide.
The 2025 Penn Colton Center Symposium convened 150+ experts to explore breakthroughs in immune health and spotlight Penn’s leadership, future headquarters, and innovations in autoimmunity research and precision medicine.
To accelerate the development of next-generation diagnostics and therapies for autoimmune disease, the Colton Center for Autoimmunity at Penn—working in partnership with the broader Colton Consortium—has launched two new Centers of Excellence.
The Colton Center for Autoimmunity at the University of Pennsylvania has issued an RFA to establish new Centers of Excellence (COEs) to transform the landscape of autoimmune research.
Dive into the inspiring stories and accomplishments of the recipients of The Philadelphia Citizen's first-ever Citizen of the Year Awards. Featuring David Fajgenbaum from the Colton Center for Autoimmunity at Penn.
On April 18, 2023, the Colton Center for Autoimmunity at Penn hosted its first annual Symposium, bringing together experts across disciplines to discuss advances in autoimmune research.
Center for autoimmune research brings together star faculty, powering next generation of autoimmune disease advances
The University of Pennsylvania's Perelman School of Medicine has launched the Colton Center for Autoimmunity, supported by a $10 million dollar donation from Stewart and Judy Colton, to enhance autoimmune research and patient care.
A promising new study published online in Cell by NYU Langone Health researchers uncovers a targeted strategy for treating autoimmune diseases such as type 1 diabetes, hepatitis, and multiple sclerosis.
The study from NYU Grossman School of Medicine found that growths of the gut bacterium Ruminococcus blautia gnavus in lupus patients coincide with disease flare-ups, suggesting a strong link between these bacterial blooms and severe forms of lupus.
The Colton Center for Autoimmune Immunity at Tel Aviv University put forth several calls for proposals to fund autoimmune disease research—learn more about the winning research teams.
New center enabled by a generous gift of $10 million from Judith and Stewart Colton
The Colton Center for Autoimmunity at Yale University presented a showcase on Colton-funded research featuring investigators from across the Consortium.
Yale researchers, including members of the Colton Center for Autoimmunity at Yale, have uncovered a novel lupus-associated autoantibody that can enhance immune responses against aggressive cancers like glioblastoma.
The Colton Center for Autoimmunity at Yale is pleased to announce the eleven 2024 Yale projects selected for their promising research in autoimmunity and allergic diseases.
Connecticut's biggest entrepreneurship event, convening innovators, investors, and industry for panels, speakers, and networking in the arts, biotech, climate, health, and tech.
The Colton Center for Autoimmunity at Yale has awarded seven faculty-led projects a total of $750K to fund research on autoimmune and allergic diseases, including celiac disease, diabetes, and inflammatory skin diseases.
Yale University has launched the Colton Center for Autoimmunity, supported by a donation from Stewart and Judy Colton, to enhance autoimmune research and patient care.
Reach out to us to explore partnership opportunities and join forces with the Colton Center for Autoimmunity Consortium in advancing groundbreaking research in autoimmune diseases.